<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01294007</url>
  </required_header>
  <id_info>
    <org_study_id>PRO-000061</org_study_id>
    <nct_id>NCT01294007</nct_id>
  </id_info>
  <brief_title>Radiographic Analysis Using PureGen Versus Autologous Bone in Posterolateral Fusion (PLF)</brief_title>
  <official_title>A Radiographic Analysis Using PureGen Osteoprogenitor Cell Allograft Versus Autologous Bone in Posterolateral Fusion in a Side-by-Side Comparison in the Same Patient (PLF)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Alphatec Spine, Inc.</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Alphatec Spine, Inc.</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the rate and quality of fusion of PureGen&#xD;
      Osteoprogenitor Cell Allograft, compared to autograft bone in instrumented posterolateral&#xD;
      fusion (PLF) procedures.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Product no longer on the market&#xD;
  </why_stopped>
  <start_date>February 2011</start_date>
  <completion_date type="Actual">November 2013</completion_date>
  <primary_completion_date type="Actual">November 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Fusion</measure>
    <time_frame>6 months</time_frame>
    <description>Proportion of subjects with fusion at the 6- and conditional 12- and 24-month visit</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">1</enrollment>
  <condition>Lumbar Degenerative Disc Disease</condition>
  <arm_group>
    <arm_group_label>Study Graft Composite</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Graft Composite</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>PureGen Osteoprogenitor Cell Allograft</intervention_name>
    <description>PureGen Osteoprogenitor Cell Allograft with posterior transpedicular fixation.</description>
    <arm_group_label>Study Graft Composite</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Autograft bone</intervention_name>
    <description>Iliac Crest and Local Autograft Bone</description>
    <arm_group_label>Control Graft Composite</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Symptomatic lumbar degenerative disc disease in up to two contiguous levels between L1&#xD;
             and S1&#xD;
&#xD;
          -  Subjects with back and/or leg pain indicated for posterior stabilization with or&#xD;
             without decompression at any level and posterolateral fusion (PLF)&#xD;
&#xD;
          -  Unresponsive to conservative treatment for at least 6 months&#xD;
&#xD;
          -  Radiographic evidence of primary diagnosis&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  More than 2 levels requiring posterolateral fusion&#xD;
&#xD;
          -  Spondylolisthesis greater than Grade I&#xD;
&#xD;
          -  Prior failed fusion surgery at any lumbar level(s)&#xD;
&#xD;
          -  Systemic or local infection in the disc or cervical spine, past or present&#xD;
&#xD;
          -  Active systemic disease&#xD;
&#xD;
          -  Osteoporosis, osteomalacia, or other metabolic bone disease that would significantly&#xD;
             inhibit bone healing&#xD;
&#xD;
          -  Use of other bone graft, Bone Morphogenetic Protein (BMP) or bone graft substitutes in&#xD;
             addition to or in place of those products specified&#xD;
&#xD;
          -  BMI greater than 40&#xD;
&#xD;
          -  Use of post operative Spinal Cord Stimulator (SCS)&#xD;
&#xD;
          -  Known or suspected history of alcohol and/or drug abuse&#xD;
&#xD;
          -  Involved in pending litigation or worker's compensation related to the spine&#xD;
&#xD;
          -  Pregnant or planning to become pregnant during the course of the study&#xD;
&#xD;
          -  Insulin-dependent diabetes mellitus&#xD;
&#xD;
          -  Life expectancy less than duration of study&#xD;
&#xD;
          -  Any significant psychological disturbance that could impair consent process or ability&#xD;
             to complete self-assessment questionnaires&#xD;
&#xD;
          -  Undergoing chemotherapy or radiation treatment, or chronic use of oral or injected&#xD;
             steroids or prolonged use of non-steroidal anti-inflammatory drugs.&#xD;
&#xD;
          -  Known history of hypersensitivity or anaphylactic reaction to dimethyl sulfoxide&#xD;
             (DMSO)&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>50 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <study_first_submitted>February 9, 2011</study_first_submitted>
  <study_first_submitted_qc>February 9, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 11, 2011</study_first_posted>
  <last_update_submitted>January 15, 2016</last_update_submitted>
  <last_update_submitted_qc>January 15, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 20, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Intervertebral Disc Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

